Breaking News Instant updates and real-time market news.

2020-04-22 05:36:28 BRX Brixmor $8.86 / -0.03 (-0.34%) 05:36 04/22/20 04/22 05:36 04/22/20 05:36	Brixmor downgraded to Neutral from Overweight at JPMorgan JPMorgan analyst Anthony Paolone downgraded Brixmor Property Group to Neutral from Overweight with an $11 price target.	28 Apr 08 May
BRX Brixmor $8.86 / -0.03 (-0.34%) 04/20/20 Evercore ISI Brixmor upgraded to Outperform from In Line at Evercore ISI 04/16/20 Compass Point Brixmor dividend appears 'safe,' says Compass Point in upgrade to Buy 04/16/20 Compass Point Brixmor upgraded to Buy from Neutral at Compass Point 03/23/20 BofA Brixmor downgraded to Neutral from Buy at BofA

2020-04-22 05:36:28

BRX

Brixmor

$8.86 / -0.03 (-0.34%)

05:36

04/22/20

04/22

05:36

04/22/20

05:36

Brixmor downgraded to Neutral from Overweight at JPMorgan

JPMorgan analyst Anthony Paolone downgraded Brixmor Property Group to Neutral from Overweight with an $11 price target.

28
Apr
08
May

BRX Brixmor

$8.86 / -0.03 (-0.34%)

04/20/20 Evercore ISI: Brixmor upgraded to Outperform from In Line at Evercore ISI

04/16/20 Compass Point: Brixmor dividend appears 'safe,' says Compass Point in upgrade to Buy

04/16/20 Compass Point: Brixmor upgraded to Buy from Neutral at Compass Point

03/23/20 BofA: Brixmor downgraded to Neutral from Buy at BofA

TODAY'S FREE FLY STORIES

Recommendations	Core-Mark price target raised to $42 from $34 at Raymond James » 08:28 03/02/21 03/02 08:28 03/02/21 08:28 CORE Core-Mark $36.09 / +3.44 (+10.54%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CORE Core-Mark $36.09 / +3.44 (+10.54%) 03/01/21 Core-Mark announces new three-year, $375M shareholder return plan 01/28/21 Murphy USA and Core-Mark renew strategic supply agreement 01/07/21 Core-Mark promotes Chris Hobson to COO, Andy Newkirk to SVP of Operations 11/05/20 Core-Mark raises quarterly dividend 8% to 13c per share CORE Core-Mark $36.09 / +3.44 (+10.54%) 01/26/21 BMO Capital Core-Mark upgraded to Outperform from Market Perform at BMO Capital 11/20/20 Jefferies Core-Mark assumed with a Hold from Buy at Jefferies CORE Core-Mark $36.09 / +3.44 (+10.54%) 03/01/21 Core-Mark sees FY21 adjusted EPS $1.90-$2.06, consensus $1.88 03/01/21 Core-Mark reports Q4 adjusted EPS 57c, consensus 31c 11/05/20 Core-Mark raises FY20 adj. EPS view to $1.62-$1.69 from $1.42-$1.59 11/05/20 Core-Mark reports Q3 EPS 51c, consensus 49c
Hot Stocks	Clever Leaves receives largest 2021 production quotas from Colombian Government » 08:27 03/02/21 03/02 08:27 03/02/21 08:27 CLVR Clever Leaves $13.84 / +0.74 (+5.65%) Clever Leaves Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly Options CLVR Clever Leaves $13.84 / +0.74 (+5.65%) 02/22/21 Clever Leaves appoints Hank Hague as CFO 02/17/21 Clever Leaves added to NYSE-listed cannabis ETF 'THCX' 02/09/21 Clever Leaves' nutraceutical manufacturer importing CBD into U.S. 01/12/21 Clever Leaves signs multi-year partnership with Entourage Phytolab CLVR Clever Leaves $13.84 / +0.74 (+5.65%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves CLVR Clever Leaves $13.84 / +0.74 (+5.65%) 03/01/21 Largest borrow rate increases among liquid names 02/26/21 Largest borrow rate increases among liquid names
Recommendations	Cardlytics price target raised to $150 from $90 at Truist » 08:26 03/02/21 03/02 08:26 03/02/21 08:26 CDLX Cardlytics $141.43 / +8.88 (+6.70%) Truist analyst Youssef… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate CDLX Cardlytics $141.43 / +8.88 (+6.70%) 03/01/21 Cardlytics to acquire Dosh for $275M in cash and stock CDLX Cardlytics $141.43 / +8.88 (+6.70%) 03/01/21 Truist Cardlytics price target raised to $150 from $90 at Truist 01/14/21 William Blair Cardlytics downgraded to Market Perform on valuation at William Blair 01/14/21 William Blair Cardlytics downgraded to Market Perform from Outperform at William Blair 12/16/20 JPMorgan Cardlytics price target raised to $110 from $82 at JPMorgan CDLX Cardlytics $141.43 / +8.88 (+6.70%) 03/01/21 Cardlytics sees FY21 revenue $250M-$275M, consensus $255.59M 03/01/21 Cardlytics sees Q1 revenue $47M-$53M, consensus $50.07M 03/01/21 Cardlytics reports Q4 adjusted EPS (5c), consensus (3c) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 03 Mar
Technical Analysis	DJ Transportation Average: Pivot points » 08:26 03/02/21 03/02 08:26 03/02/21 08:26 $DJT DJ Transportation Average $0.00 / + (+0.00%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $DJT DJ Transportation Average $0.00 / + (+0.00%) 03/01/21 DJ Transportation Average: Pivot points 02/26/21 DJ Transportation Average: Pivot points 02/25/21 DJ Transportation Average: Pivot points 02/24/21 DJ Transportation Average: Pivot points
Hot Stocks	Enzo Biochem says GENFLEX test detects COVID-19 variants » 08:26 03/02/21 03/02 08:26 03/02/21 08:26 ENZ Enzo Biochem $2.96 / +0.02 (+0.68%) Enzo Biochem announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events Options ENZ Enzo Biochem $2.96 / +0.02 (+0.68%) 02/04/21 180 Degree Capital urges Enzo Biochem to accept Rabbani resignation immediately 02/03/21 Enzo Biochem announces issuance of U.S. patent for polyclonal antibodies 01/20/21 Enzo Biochem board forms corporate development, planning & succession committees 01/04/21 Harbert says Enzo refused to disclose preliminary shareholder votes ENZ Enzo Biochem $2.96 / +0.02 (+0.68%) 11/17/20 Enzo Biochem sees Q1 revenue up 'at least 40%' from Q4, two board members resign ENZ Enzo Biochem $2.96 / +0.02 (+0.68%) 11/17/20 Fly Intel: Pre-market Movers 03/15/21 Enzo Biochem - ENZ ENZ Enzo Biochem $2.96 / +0.02 (+0.68%) 10/13/20 Enzo Biochem options imply 18.6% move in share price post-earnings

Downgrade	Trend Micro downgraded to Hold from Buy at Jefferies » 08:26 03/02/21 03/02 08:26 03/02/21 08:26 TMICY Trend Micro $0.00 / + (+0.00%) Jefferies analyst Hiroko… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research TMICY Trend Micro $0.00 / + (+0.00%) 02/24/21 Citi Trend Micro downgraded to Sell from Neutral at Citi 10/22/20 Jefferies Trend Micro upgraded to Buy from Hold at Jefferies 09/28/20 Goldman Sachs Trend Micro initiated with a Buy at Goldman Sachs 08/25/20 Citi Trend Micro upgraded to Neutral from Sell at Citi
Technical Analysis	DJ Utility Average: Pivot points » 08:26 03/02/21 03/02 08:26 03/02/21 08:26 $DJU DJ Utility Average $0.00 / + (+0.00%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $DJU DJ Utility Average $0.00 / + (+0.00%) 03/01/21 DJ Utility Average: Pivot points 02/26/21 DJ Utility Average: Pivot points 02/25/21 DJ Utility Average: Pivot points 02/24/21 DJ Utility Average: Pivot points
Technical Analysis	Dow Jones Industrial Average: Pivot points » 08:26 03/02/21 03/02 08:26 03/02/21 08:26 DJX Dow Jones Industrial Average $0.00 / + (+0.00%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Periodicals Technical Analysis DJX Dow Jones Industrial Average $0.00 / + (+0.00%) 10/10/20 Stimulus deal chances before election 'extremely remote,' Washington Post says DJX Dow Jones Industrial Average $0.00 / + (+0.00%) 03/01/21 Dow Jones Industrial Average: Pivot points 02/26/21 Dow Jones Industrial Average: Pivot points 02/25/21 Dow Jones Industrial Average: Pivot points 02/24/21 Dow Jones Industrial Average: Pivot points
Technical Analysis	iShares Transportation Average: Pivot points » 08:25 03/02/21 03/02 08:25 03/02/21 08:25 IYT iShares Transportation Average $240.02 / +2.88 (+1.21%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis IYT iShares Transportation Average $240.02 / +2.88 (+1.21%) 03/01/21 iShares Transportation Average: Pivot points 02/26/21 iShares Transportation Average: Pivot points 02/25/21 iShares Transportation Average: Pivot points 02/24/21 iShares Transportation Average: Pivot points
Syndicate	RedHill Biopharma raises previously announced bought deal to $35M of ADSs » 08:25 03/02/21 03/02 08:25 03/02/21 08:25 RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) RedHill Biopharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 02/23/21 RedHill Biopharma to expand opaganib global Phase 2/3 COVID-19 study 01/29/21 RedHill Biopharma announces independent DSMB recommendation for opaganib 01/06/21 RedHill Biopharma's RHB-204 granted FDA Fast Track designation for NTM disease 12/31/20 RedHill Biopharma announces safety, efficacy data from Phase 2 COVID-19 study RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 11/12/20 Roth Capital RedHill Biopharma price target lowered to $12 from $16 at Roth Capital 09/11/20 BTIG RedHill Biopharma initiated with a Buy at BTIG 08/14/20 Roth Capital Roth Capital maintains Buy on RedHill after 'noisy' quarter 07/07/20 SMBC Nikko RedHill Biopharma initiated with an Outperform at SMBC Nikko RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 11/12/20 RedHill Biopharma reports Q3 EPS (5c), consenus (16c) 02 Mar RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 03/01/21 Fly Intel: After-Hours Movers

Technical Analysis	Technology Select Sector SPDR: Pivot points » 08:25 03/02/21 03/02 08:25 03/02/21 08:25 XLK Technology Select Sector SPDR $134.81 / +4.09 (+3.13%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Options Technical Analysis XLK Technology Select Sector SPDR $134.81 / +4.09 (+3.13%) 06/10/20 Jefferies Jefferies downgrades Tech sector to Market Weight from Overweight XLK Technology Select Sector SPDR $134.81 / +4.09 (+3.13%) 10/02/20 Unusually active option classes on open October 2nd XLK Technology Select Sector SPDR $134.81 / +4.09 (+3.13%) 03/01/21 Technology Select Sector SPDR: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 Technology Select Sector SPDR: Pivot points 02/25/21 Technology Select Sector SPDR: Pivot points
Recommendations	Semler Scientific price target raised to $147 from $121 at B. Riley Securities » 08:25 03/02/21 03/02 08:25 03/02/21 08:25 SMLR Semler Scientific $0.00 / + (+0.00%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SMLR Semler Scientific $0.00 / + (+0.00%) 02/25/21 B. Riley Securities Semler Scientific price target raised to $121 from $100 at B. Riley Securities 01/19/21 B. Riley Securities Semler Scientific price target raised to $100 from $94 at B. Riley Securities 11/06/20 Lake Street Semler Scientific price target raised to $100 from $75 at Lake Street 06/23/20 B. Riley FBR Semler Scientific initiated with a Buy at B. Riley FBR
Hot Stocks	Pluralsight to adjourn special meeting of shareholders » 08:24 03/02/21 03/02 08:24 03/02/21 08:24 PS Pluralsight $20.53 / -0.07 (-0.34%) Pluralsight announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PS Pluralsight $20.53 / -0.07 (-0.34%) 02/18/21 Pluralsight 'strongly believes' ISS 'reached the wrong conclusion' 02/17/21 ISS recommends Pluralsight shareholders vote against Vista transaction 02/09/21 Pluralsight and Degreed partner in technology upskilling programs 02/04/21 Pluralsight Skills to integrate with Microsoft Viva PS Pluralsight $20.53 / -0.07 (-0.34%) 01/04/21 Truist Pluralsight downgraded to Hold from Buy at Truist 01/04/21 Truist Pluralsight downgraded to Hold from Buy at Truist 12/17/20 Barclays Pluralsight downgraded to Equal Weight from Overweight at Barclays 12/15/20 Baird Pluralsight downgraded to Neutral from Outperform at Baird PS Pluralsight $20.53 / -0.07 (-0.34%) 02/10/21 Pluralsight reports Q4 adjusted EPS (1c), consensus (2c) 11/05/20 Pluralsight sees FY20 EPS 12c-14c, consensus (23c) 11/05/20 Pluralsight reports Q3 EPS 0c, consensus (6c) 10 Jun PS Pluralsight $20.53 / -0.07 (-0.34%) 11/10/20 Betaville speculates on PE interest in Pluralsight, Bloomberg says PS Pluralsight $20.53 / -0.07 (-0.34%) 12/14/20 Fly Intel: Pre-market Movers 11/06/20 Square, AMD upgrades among today's top calls on Wall Street 11/05/20 Fly Intel: After-Hours Movers 12:30 Today Pluralsight, Inc. 04/05/21 Pluralsight PS Pluralsight $20.53 / -0.07 (-0.34%) 11/12/20 Unusually active option classes on open November 12th
Technical Analysis	Energy Select Sector SPDR: Pivot points » 08:24 03/02/21 03/02 08:24 03/02/21 08:24 XLE Energy Select Sector SPDR $49.40 / +1.25 (+2.60%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options Technical Analysis XLE Energy Select Sector SPDR $49.40 / +1.25 (+2.60%) 12/29/20 Alpha One Capital's Dan Niles likes JPMorgan, Oracle, Magna Intl, Gan Ltd in '21 XLE Energy Select Sector SPDR $49.40 / +1.25 (+2.60%) 07/06/20 Goldman Sachs Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs XLE Energy Select Sector SPDR $49.40 / +1.25 (+2.60%) 01/20/21 Vertical call spread in energy ETF targets 26% return for 2021 01/08/21 Size call sale in Energy ETF likely closes December trade 12/14/20 Unusually active option classes on open December 14th XLE Energy Select Sector SPDR $49.40 / +1.25 (+2.60%) 03/01/21 Energy Select Sector SPDR: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 Energy Select Sector SPDR: Pivot points 02/25/21 Energy Select Sector SPDR: Pivot points
Technical Analysis	Consumer Discretionary Sector SPDR: Pivot points » 08:24 03/02/21 03/02 08:24 03/02/21 08:24 XLY Consumer Discretionary Sector SPDR $164.93 / +3.67 (+2.28%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Options Technical Analysis XLY Consumer Discretionary Sector SPDR $164.93 / +3.67 (+2.28%) 03/18/20 Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight XLY Consumer Discretionary Sector SPDR $164.93 / +3.67 (+2.28%) 02/19/21 Unusually active option classes on open February 19th 11/18/20 Unusually active option classes on open November 18th 11/16/20 Unusually active option classes on open November 16th XLY Consumer Discretionary Sector SPDR $164.93 / +3.67 (+2.28%) 03/01/21 Consumer Discretionary Sector SPDR: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 Consumer Discretionary Sector SPDR: Pivot points 02/25/21 Consumer Discretionary Sector SPDR: Pivot points

Technical Analysis	S&P Select Materials SPDR: Pivot points » 08:24 03/02/21 03/02 08:24 03/02/21 08:24 XLB S&P Select Materials SPDR $75.40 / +1.85 (+2.52%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Options Technical Analysis XLB S&P Select Materials SPDR $75.40 / +1.85 (+2.52%) 06/10/20 Jefferies Jefferies downgrades Tech sector to Market Weight from Overweight XLB S&P Select Materials SPDR $75.40 / +1.85 (+2.52%) 01/06/21 Largest borrow rate increases among liquid names 10/29/20 Unusually active option classes on open October 29th XLB S&P Select Materials SPDR $75.40 / +1.85 (+2.52%) 03/01/21 S&P Select Materials SPDR: Pivot points 02/26/21 S&P Select Materials SPDR: Pivot points 02/25/21 S&P Select Materials SPDR: Pivot points 02/24/21 S&P Select Materials SPDR: Pivot points
Recommendations	Sarepta price target lowered to $132 from $143 at RBC Capital » 08:24 03/02/21 03/02 08:24 03/02/21 08:24 SRPT Sarepta $86.94 / -0.07 (-0.08%) RBC Capital analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SRPT Sarepta $86.94 / -0.07 (-0.08%) 02/25/21 Sarepta rallies 2% to $86.15 after winning FDA approval for DMD treatment 02/25/21 Sarepta announces FDA approval of Amondys 45 02/08/21 Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs 01/13/21 Sarepta, Genevant announce collaboration for gene editing therapeutics SRPT Sarepta $86.94 / -0.07 (-0.08%) 05:05 Today Piper Sandler Sarepta price target lowered to $130 from $140 at Piper Sandler 02/26/21 Mizuho Sarepta price target raised to $160 from $158 at Mizuho 02/25/21 Piper Sandler Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label' 02/09/21 Morgan Stanley Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley SRPT Sarepta $86.94 / -0.07 (-0.08%) 03/01/21 Sarepta reports Q4 EPS ($1.84), consensus ($1.77) 03/01/21 Sarepta reports Q4 EPS ($1.84), consensus ($1.77) 11/05/20 Sarepta reports Q3 EPS ($2.50), consensus ($1.71) SRPT Sarepta $86.94 / -0.07 (-0.08%) 03/01/21 Fly Intel: After-Hours Movers 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 00:00 Today 41st Annual Healthcare Virtual Conference
Technical Analysis	Utilities SPDR: Pivot points » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 XLU Utilities SPDR $59.61 / +1.26 (+2.16%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Technical Analysis XLU Utilities SPDR $59.61 / +1.26 (+2.16%) 10/21/20 Jefferies Jefferies upgrades Utilities sector to Market Weight from Underweight 10/19/20 Goldman Sachs Essential Utilities upgraded to Conviction Buy from Neutral at Goldman Sachs XLU Utilities SPDR $59.61 / +1.26 (+2.16%) 03/01/21 Utilities SPDR: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 Utilities SPDR: Pivot points 02/25/21 Utilities SPDR: Pivot points
Conference/Events	Tailwind Acquisition to host business news update conference call » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 TWND Tailwind Acquisition $10.89 / +0.34 (+3.22%) Management of QOMPLX and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< On The Fly TWND Tailwind Acquisition $10.89 / +0.34 (+3.22%) 09/06/20 Opening Day: PainReform raises $23M in Nasdaq IPO
Recommendations	Precigen price target raised to $14 from $10 at B. Riley Securities » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 PGEN Precigen $8.20 / -0.25 (-2.96%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PGEN Precigen $8.20 / -0.25 (-2.96%) 01/05/21 Precigen announces FDA clearance of IND application for PRGN-2012 12/07/20 Precigen: PRGN-3006 safe, well-tolerated to date 11/16/20 Precigen announces dosing of first patients in ongoing PRGN-3005, -3006 trials 10/15/20 Precigen's UltraPorator system receives FDA clearance PGEN Precigen $8.20 / -0.25 (-2.96%) 02/25/21 Stifel Precigen initiated with a Buy at Stifel 02/22/21 Wells Fargo Precigen initiated with an Overweight at Wells Fargo 02/18/21 Fly Intel: Top five analyst initiations 02/18/21 B. Riley Securities Precigen initiated with a Buy at B. Riley Securities PGEN Precigen $8.20 / -0.25 (-2.96%) 03/01/21 Precigen reports Q4 EPS (22c), consensus (17c) 11/09/20 Precigen reports Q3 EPS (18c), consensus (14c) 22 Jan PGEN Precigen $8.20 / -0.25 (-2.96%) 01/21/21 Fly Intel: After-Hours Movers PGEN Precigen $8.20 / -0.25 (-2.96%) 12/11/20 Largest borrow rate increases among liquid names

Technical Analysis	Consumer Staples Sector SPDR: Pivot points » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 XLP Consumer Staples Sector SPDR $63.94 / +0.65 (+1.03%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis XLP Consumer Staples Sector SPDR $63.94 / +0.65 (+1.03%) 03/01/21 Consumer Staples Sector SPDR: Pivot points 02/26/21 Consumer Staples Sector SPDR: Pivot points 02/25/21 Consumer Staples Sector SPDR: Pivot points 02/24/21 Consumer Staples Sector SPDR: Pivot points
Technical Analysis	Health Care Select Sector SPDR: Pivot points » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 XLV Health Care Select Sector SPDR $114.01 / +1.35 (+1.20%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Options Technical Analysis XLV Health Care Select Sector SPDR $114.01 / +1.35 (+1.20%) 03/18/20 Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight XLV Health Care Select Sector SPDR $114.01 / +1.35 (+1.20%) 02/19/21 Unusually active option classes on open February 19th 01/11/21 Opening put Seller in Health Care SPDR ETF 10/30/20 Largest borrow rate increases among liquid names XLV Health Care Select Sector SPDR $114.01 / +1.35 (+1.20%) 03/01/21 Health Care Select Sector SPDR: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 Health Care Select Sector SPDR: Pivot points 02/25/21 Health Care Select Sector SPDR: Pivot points
Technical Analysis	iShares Trust Russell 2000 Index Fund: Pivot points » 08:22 03/02/21 03/02 08:22 03/02/21 08:22 IWM iShares Trust Russell 2000 Index Fund $226.15 / +7.85 (+3.60%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Periodicals Technical Analysis IWM iShares Trust Russell 2000 Index Fund $226.15 / +7.85 (+3.60%) 11/25/20 Partial shutdown in Germany extended amid virus uptick, Bloomberg says 10/13/20 UK science experts say brief lockdown would prevent Covid-19 deaths, FT reports IWM iShares Trust Russell 2000 Index Fund $226.15 / +7.85 (+3.60%) 03/01/21 iShares Trust Russell 2000 Index Fund: Pivot points 02/26/21 On The Fly: Weekly technical notes for Russell 2000 02/26/21 iShares Trust Russell 2000 Index Fund: Pivot points 02/25/21 iShares Trust Russell 2000 Index Fund: Pivot points
Technical Analysis	Diamonds Fund ETF: Pivot points » 08:22 03/02/21 03/02 08:22 03/02/21 08:22 DIA Diamonds Fund ETF $315.49 / +6.11 (+1.97%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Periodicals Options Technical Analysis DIA Diamonds Fund ETF $315.49 / +6.11 (+1.97%) 11/25/20 Partial shutdown in Germany extended amid virus uptick, Bloomberg says 11/23/20 Biden to nominate Janet Yellen for Treasury Secretary,WSJ says 10/13/20 UK science experts say brief lockdown would prevent Covid-19 deaths, FT reports 09/21/20 UK coronavirus alert level to be raised from 3 to 4, Guardian reports DIA Diamonds Fund ETF $315.49 / +6.11 (+1.97%) 02/17/21 Unusually active option classes on open February 17th 10/06/20 Unusually active option classes on open October 6th DIA Diamonds Fund ETF $315.49 / +6.11 (+1.97%) 03/01/21 Diamonds Fund ETF: Pivot points 02/26/21 Diamonds Fund ETF: Pivot points 02/25/21 Diamonds Fund ETF: Pivot points 02/24/21 Diamonds Fund ETF: Pivot points
Hot Stocks	Acutus Medical receives Vizient innovative technology contract » 08:22 03/02/21 03/02 08:22 03/02/21 08:22 AFIB Acutus Medical $21.37 / +0.59 (+2.84%) Acutus Medical announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate AFIB Acutus Medical $21.37 / +0.59 (+2.84%) 08:16 Today Acutus Medical appoints Duane Wilder as CCO 02/09/21 Acutus Medical appoints David Roman CFO 12/10/20 Acutus Medical announces CE Mark, European launch of AcQCross Transseptal System 12/07/20 Acutus Medical launches AcQBlate Force Sensing Ablation System in Europe AFIB Acutus Medical $21.37 / +0.59 (+2.84%) 01/14/21 BofA Acutus Medical downgraded to Neutral from Buy at BofA 08/31/20 Fly Intel: Top five analyst initiations 08/31/20 JPMorgan Acutus Medical initiated with an Overweight at JPMorgan 08/31/20 William Blair Acutus Medical initiated with an Outperform at William Blair AFIB Acutus Medical $21.37 / +0.59 (+2.84%) 01/13/21 Acutus Medical sees 2020 revenue $8.3M-$8.5M, consensus $10.97M 01/13/21 Acutus Medical sees Q4 revenue $2.4M-$2.6M, consensus $5.05M 11/12/20 Acutus Medical reports Q3 EPS ($1.95), consensus (99c) 09/17/20 Acutus Medical reports Q2 EPS ($32.24) vs ($45.70) last year 06 Aug

Events

Earnings calls, analyst events, roadshows and more

TWND
Today at 08:30

Tailwind Acquisition - TWND Conference Calls
ANF
Today at 08:30

Abercrombie & Fitch - ANF Conference Calls
ATRS
Today at 08:30

Antares Pharma - ATRS Conference Calls
DDD
Today at 08:30

3D Systems - DDD Conference Calls
MDCA
Today at 08:30

MDC Partners - MDCA Conference Calls
KTB
Today at 08:30

Kontoor Brands - KTB Conference Calls
TTEC
Today at 08:30

TTEC Holdings - TTEC Conference Calls
TXMD
Today at 08:30

TherapeuticsMD - TXMD Conference Calls
WSTG
Today at 08:30

Wayside Technology - WSTG Conference Calls
KOPN
Today at 08:30

Kopin - KOPN Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley $84.00-84.50 1.2M Shares FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley $166.50-169.95 1.5M Shares HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan $88.25-89.25 1.45M Shares RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Brixmor downgraded to Neutral from Overweight at JPMorgan

TODAY'S FREE FLY STORIES

Get Full Fly Access